Literature DB >> 30674116

Dynamics and implications of models for intermittent androgen suppression therapy.

Tin Phan1, Changhan He, Alejandro Martinez, Yang Kuang.   

Abstract

In this paper, we formulate a three cell population model of intermittent androgen suppression therapy for cancer patients to study the treatment resistance development. We compare it with other models that have different underlying cell population structure using patient prostate specific antigen (PSA) and androgen data sets. Our results show that in the absence of extensive data, a two cell population structure performs slightly better in replicating and forecasting the dynamics observed in clinical PSA data. We also observe that at least one absorbing state should be present in the cell population structure of a plausible model for it to produce treatment resistance under continuous hormonal therapy. This suggests that the heterogeneity of prostate cancer cell population can be represented by two types of cells differentiated by their level of dependence on androgen, where the two types are linked via an irreversible transformation.

Entities:  

Keywords:  cell quota model ; data fitting ; hormonal therapy ; population structure ; predict treatment outcome ; prostate cancer modeling

Mesh:

Substances:

Year:  2018        PMID: 30674116     DOI: 10.3934/mbe.2019010

Source DB:  PubMed          Journal:  Math Biosci Eng        ISSN: 1547-1063            Impact factor:   2.080


  2 in total

1.  Intermittent Hormone Therapy Models Analysis and Bayesian Model Comparison for Prostate Cancer.

Authors:  S Pasetto; H Enderling; R A Gatenby; R Brady-Nicholls
Journal:  Bull Math Biol       Date:  2021-11-19       Impact factor: 1.758

2.  High Accuracy Indicators of Androgen Suppression Therapy Failure for Prostate Cancer-A Modeling Study.

Authors:  William Meade; Allison Weber; Tin Phan; Emily Hampston; Laura Figueroa Resa; John Nagy; Yang Kuang
Journal:  Cancers (Basel)       Date:  2022-08-20       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.